[PDF][PDF] The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients …
SR Lakhani, MJ Van De Vijver, J Jacquemier… - Journal of clinical …, 2002 - core.ac.uk
SR Lakhani, MJ Van De Vijver, J Jacquemier, TJ Anderson, PP Osin, L McGuffog, DF Easton
Journal of clinical oncology, 2002•core.ac.ukThe Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers
Estrogen Receptor, Progesterone Recepto Page 1 The Pathology of Familial Breast Cancer:
Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor,
HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2 By Sunil R. Lakhani, Marc
J. van de Vijver, Jocelyne Jacquemier, Thomas J. Anderson, Peter P. Osin, Lesley McGuffog,
and Douglas F. Easton for the Breast Cancer Linkage Consortium Purpose: The morphologic …
Estrogen Receptor, Progesterone Recepto Page 1 The Pathology of Familial Breast Cancer:
Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor,
HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2 By Sunil R. Lakhani, Marc
J. van de Vijver, Jocelyne Jacquemier, Thomas J. Anderson, Peter P. Osin, Lesley McGuffog,
and Douglas F. Easton for the Breast Cancer Linkage Consortium Purpose: The morphologic …
Purpose: The morphologic and molecular pheno-type of breast cancers may help identify patients who are likely to carry germline mutations in BRCA1 and
core.ac.uk